Please assess the completion status of the following clinical trial:

Trial Title: Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and non-pregnant female \> 18 years of age admitted to Surgical ICUs with suspected infection~* Calculated creatinine clearance \> 60ml/min~Exclusion Criteria:~* Age \< 18 years~* Allergic to vancomycin~* Calculated creatinine clearance \< 60ml/min~* Pregnant~* Vancomycin administration more than 8 hour and less than 24 hour prior to study enrollment~* Anticipated vancomycin treatment less than 2 days for surgical prophylaxis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vancomycin with continuous infusion (Type: EXPERIMENTAL): 24 hours continuous infusion
- Vancomycin with intermittent dose interval (Type: ACTIVE_COMPARATOR): infusion rate 1000mg/hr

Based on this trial design, predict the completion outcome and termination type (if applicable).